FlandersBio on Twitter

Follow us on Twitter

Archive for July 2011 - News

Archive for July 2011 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

MDxHealth's MGMT Test Shown to Be Only Prognostic Factor in Journal of Clinical Oncology Report on Newly Diagnosed Brain Cancer Patients


MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that its MGMT test (PredictMDx(TM) for Brain) was shown to be the only prognostic factor for overall survival (OS) in newly diagnosed glioblastoma multiforme (GBM) patients over the age of 70 in a study published in the Journal of Clinical Oncology (JCO)*, one of the leading cancer journals. Prognostic factors are biological markers that help determine the course and outcome of disease. The study was conducted by eight of the foremost French academic institutions to evaluate the efficacy and safety of temozolomide alone in what is considered a fragile patient population, suffering from this devastating type of brain cancer. read more

Dafra Pharma Research & Development and MT-Derm selected to participate in a Grand Challenges Canada funded project to deliver an experimental anti-leishmaniasis drug with a tattoo device


On June 29th, 2011 the non-profit Grand Challenges Canada announced 19 recipients of its first round $100,000 grant for the Rising Stars in Global Health program. The project granted to adjunct biochemist of McGill University Dr. Anny Fortin proposed to use a permanent make-up (PMU, or tattoo) device to target intra-dermal delivery of a new anti-cutaneous leishmaniasis therapy, a debilitating and disfiguring disease caused by the bites of sandflies. read more

Biocartis strengthens management team with new CFO


Biocartis is pleased to announce that Ms. Hilde Windels has been appointed as Chief Financial Officer ("CFO") of the Biocartis group. As of July 1, Hilde Windels will also assume the role of managing director (“Gedelegeerd bestuurder”) of Biocartis NV and director of Biocartis BV. Biocartis NV is a wholly-owned subsidiary of Biocartis SA (Switzerland – Lausanne) located in Mechelen. Biocartis BV is the Dutch subsidiary in Eindhoven. read more

Galapagos increases share capital through warrant exercises


Galapagos NV (Euronext: GLPG) announced today a capital increase arising from employee warrant exercises. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top